News
Global Headlines New York: Pfizer Inc.and BioNTech SE have announced topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in individuals aged between 12 through 15 years, where it was found that two-dose series showed 100 percent efficiency against the virus after four months. more